IceCure Medical Ltd. ICCM 深 沪
等待开盘 06-26 09:30:00 美东时间
7.02
-2.280
-24.52%
华盛通- 最 高9.43
- 今 开8.40
- 成交量 144.35万股
- 最 低 5.61
- 昨 收 9.30
- 总市值 25.12万
- 52周最高 9.54
- 市盈率 静 --
- 换手率 4034.19%
- 52周最低 0.125
- 委 比 68.99%
- 总股本 3.58万
- 历史最高 12.40
- 量 比 0.04
- 振 幅 41.08%
- 历史最低 0.125
- 每 手 1
- 风险率 0.88%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多IceCure Medical Regains Nasdaq Compliance
IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to
06-25 20:13
IceCure Stock Surges After 70% ProSense Install Increase
IceCure Medical shares are soaring Wednesday after reporting a 70% jump in U.S. installs of its ProSense breast cancer cryoablation system.
06-18 00:45
Crude Oil Edges Higher; US Retail Sales Top Estimates
U.S. stocks up, Dow Jones gains 0.39%. NASDAQ rose 0.09%, S&P 500 up 0.11%. Industrials shares jump 0.9%, while communication services fall 1.7%.
06-18 00:06
US Stocks Edge Higher; CarMax Posts Upbeat Earnings
US stocks gain in morning trading, Dow up 0.1%. Tech sector leads gains, while communication services fall. CarMax beats earnings expectations.
06-17 21:45
IceCure Medical Features Cryoablation And ProSense At Annual ECIO 2026
At the annual European Conference on Interventional Oncology, ICESECRET data presented demonstrated 89.4% recurrence-free rate in patients with tumors ≤3 cm and 83.9% of patients remained recurrence-free at a median
05-19 20:41
IceCure Medical CFO Ronen Tsimerman Departing
IceCure Medical Ltd. (NASDAQ:ICCM) ("IceCure", "IceCure Medical" or the "Company"), a developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today
02-10 05:32
IceCure Announces FDA Advisory Panel Meeting Date For Marketing Authorization Of ProSense In Early-Stage Low Risk Breast Cancer Scheduled For November 7, 2024
Public forum to evaluate ProSense® cryoablation as a minimally invasive alternative to lumpectomy for an estimated 70,000 women diagnosed in U.S. annually with early-stage low risk breast cancerFDA decision
2024-09-12 20:09
USPTO Grants Notice Of Allowance For Additional Patent On IceCure's Novel 'Cryogenic Pump' Technology, Reinforcing Co's Global IP Leadership in Cryoablation Technologies
Further broadens the uses and applications of IceCure's cryoablation platform into a wide range of technology fields Over 50patents issued and allowed worldwide for IceCure's platform cryoablation technology CAESAREA, Israel, Aug. 28, 2024 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ:ICCM) ("IceCure...
2024-08-28 20:32
HC Wainwright & Co. Maintains Buy on Icecure Medical, Lowers Price Target to $2.5
HC Wainwright & Co. analyst Yi Chen maintains Icecure Medical (NASDAQ:ICCM) with a Buy and lowers the price target from $3 to $2.5.
2024-08-21 19:53
Icecure Medical Q2 2024 GAAP EPS $(0.06) Beats $(0.07) Estimate, Sales $1.01M Beat $925.50K Estimate
Icecure Medical (NASDAQ:ICCM) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.07) by 14.29 percent. The company reported quarterly sales of $1.01 million which beat the analyst consensus estimate of $925.50 thousand by 9.24 percent. This is a 7.90 perc...
2024-08-20 20:39
